Clinical Trials Sponsored by Anchora Medical

Total 55339 results

Anchora Medical

Recruiting

Laparoscopic Ventral Hernia Repair With Routine Defect Closure Using Su2ura® Approximation Device

Ventral Hernia

Israel
Anchora Medical

Recruiting

Laparoscopic Primary Umbilical Hernia Repair With Routine Defect Closure Using Su2ura Approximation Device

Primary Umbilical Hernia

Israel, Slovenia
Amphora Medical, Inc.

Terminated

Cystoscopic Ablation Via RF Energy Clinical Trial (CARETI)

Overactive Bladder

Canada, Belgium
Andhra Medical College

Completed

Oral Carvedilol in Escalating Doses in the Acute Treatment of Atrial Fibrillation

Atrial Fibrillation
Andhra Medical College

Completed

Acute Cardiovascular Effects of Cigarette Smoking

Smoking

India
Andhra Medical College

Completed

Prehypertension Among Medical Students in Visakhapatnam and Association With Cardiovascular Risk Factors

Prehypertension | Cardiovascular Risk Factors

India
Ancora Heart, Inc.

Active, not recruiting

Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation (CorCinch-PMVI)

Heart Failure | Cardiomyopathy, Dilated

United States
Ancora Heart, Inc.

Active, not recruiting

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Heart Failure | Mitral Valve Insufficiency | Cardiomyopathies

United States
Ancora Heart, Inc.

Completed

A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch® Ventricular Repair System - The CINCH-2 Study (CINCH-2)

Mitral Regurgitation | Mitral Valve Regurgitation | Functional Mitral Regurgitation

Austria, Lithuania, Germany
Ancora Heart, Inc.

Completed

Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function (LVRESTORESA)

Functional Mitral Regurgitation

Colombia
Ancora Heart, Inc.

Recruiting

Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Dilated Cardiomyopathy | Heart Failure With Reduced Ejection Fraction (HFrEF)

United States, France, Netherlands, Czechia, Belarus, Belgium, Serbia
Ancora Heart, Inc.

Active, not recruiting

Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study

Heart Failure | Cardiomyopathies

France, Netherlands, Switzerland, Czechia, Poland, Lithuania, Belarus, Belgium, Italy, United Kingdom
Ancora Heart, Inc.

Active, not recruiting

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction (CorCinch-HFrEF)

Heart Failure | Cardiomyopathy, Dilated

United States
Ancora Heart, Inc.

Withdrawn

Safety and Performance of the AccuCinch® System

Heart Failure | Mitral Valve Insufficiency
Ancora Heart, Inc.

Completed

Feasibility of the AccuCinch® System for Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function (LVRECOVER)

Severe Functional Mitral Regurgitation and Heart Failure

Australia
Anthera Pharmaceuticals

Completed

BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration

IgA Nephropathy

Czechia, Germany, Hong Kong, Korea, Republic of, Malaysia, Philippines, Singapore, Taiwan, Thailand, United Kingdom
Anthera Pharmaceuticals

Completed

FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes (FRANCIS-ACS)

Acute Coronary Syndrome

Russian Federation, Georgia, Ukraine
Anthera Pharmaceuticals

Terminated

A Study of Varespladib Infusion in Subjects With Sickle Cell Disease. (IMPACTS-2)

Sickle Cell Disease | Vaso-occlusive Crisis

United States
Anthera Pharmaceuticals

Completed

A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321

Systemic Lupus Erythematosus

United States, Argentina, Brazil, Chile, Colombia, Hong Kong, India, Mexico, Peru, Philippines, Taiwan
Anthera Pharmaceuticals

Terminated

VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome (VISTA-16)

Acute Coronary Syndrome

United States, Australia, Canada, Czech Republic, Georgia, Germany, Hungary, India, Italy, Korea, Republic of, Lebanon, Netherlands, New Zealand, Poland, Russian Federation, Spain, Ukraine
Anthera Pharmaceuticals

Terminated

A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function

Renal Impairment

United States
Anthera Pharmaceuticals

Completed

Study to Assess the Metabolism and Elimination of [14C]-Labeled Varespladib Methyl in Healthy Male Subjects

Healthy Volunteers

United States
Anthera Pharmaceuticals

Completed

SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States, Hungary, Israel, Poland, Spain, Canada, Czechia
Anthera Pharmaceuticals

Completed

SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis (SIMPLICITY)

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States
Anthera Pharmaceuticals

Withdrawn

CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Systemic Lupus Erythematosus
Anthera Pharmaceuticals

Withdrawn

BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis (BIANCA-SC)

Microscopic Polyangiitis | Granulomatosis With Polyangiitis
Anthera Pharmaceuticals

Withdrawn

BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy

IgA Nephropathy
Anthera Pharmaceuticals

Terminated

Phase III ALTU-135 CP Safety Trial (DIGEST CP)

Exocrine Pancreatic Insufficiency

United States
Anthera Pharmaceuticals

Completed

Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency (DIGEST)

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States
Anthera Pharmaceuticals

Completed

PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus (PEARL-SC)

Systemic Lupus Erythematosus

United States, Argentina, Brazil, Chile, Colombia, Hong Kong, India, Mexico, Peru, Philippines, Taiwan
Anthera Pharmaceuticals

Completed

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease (PLASMA 2)

Coronary Artery Disease

United States
Anthera Pharmaceuticals

Completed

EASY: Extended Access to Sollpura Over Years

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States, Hungary, Israel, Poland, Spain, Czechia
Anthera Pharmaceuticals

Unknown

RESULT: Reliable, Emergent Solution Using Liprotamase Treatment

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States, Hungary, Israel, Lithuania, Poland, Spain, United Kingdom
Anthera Pharmaceuticals

Terminated

CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Systemic Lupus Erythematosus

Georgia
Anthera Pharmaceuticals

Completed

CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus (CHABLIS-SC1)

Systemic Lupus Erythematosus

Georgia, Belarus, Brazil, Colombia, Guatemala, Hong Kong, India, Korea, Republic of, Malaysia, Mexico, Philippines, Russian Federation, Singapore, Sri Lanka, Taiwan, Thailand
Anthera Pharmaceuticals

Withdrawn

MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP

Idiopathic Thrombocytopenic Purpura | Immune Thrombocytopenic Purpura
Anthera Pharmaceuticals

Completed

Open-Label Phase III Long-Term Safety Trial of Liprotamase (DIGEST)

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States
Anthera Pharmaceuticals

Completed

IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome

Sickle Cell Disease | Acute Chest Syndrome | Vaso-occlusive Crisis

United States
Anthera Pharmaceuticals

Completed

PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease (PLASMA)

Coronary Artery Disease (CAD)

United States, Ukraine
Encora, Inc.

Recruiting

Upper Limb Tremor Reduction in Essential Tremor Patients (ULTRE)

Essential Tremor

United States
PPsanalytics
AnchorDx Medical Co., Ltd.; Specialty Networks

Recruiting

Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay

Bladder Cancer

United States
University of Alaska Anchorage

Completed

Step Away: Comparing a Chatbot-delivered Alcohol Intervention With a Smartphone App

Alcohol Use Disorder | Alcohol Consumption

United States
Sanatorio Anchorena San Martin

Completed

Characteristics of Weaning From Mechanical Ventilation in COVID-19 (CovWean)

COVID-19 | Respiration, Artificial

Argentina
Sanatorio Anchorena San Martin

Completed

Healthcare-associated Infections in Severe COVID-19 During 2020 (COVIACS)

COVID-19 | Respiration, Artificial | Health Care Associated Infection

Argentina
Radboud University Medical Center
Cochlear Bone Anchored Solutions

Recruiting

Single-stage Surgery Using the BI300 Implant

Hearing Impaired Children | Hearing Impairment, Conductive

Netherlands
Radboud University Medical Center
Cochlear Bone Anchored Solutions

Completed

10-year Follow-up of a Wide Diameter Bone Anchored Hearing Implant

Hearing Loss

Netherlands
Maastricht University Medical Center
Cochlear Bone Anchored Solutions

Unknown

The Baha Microbiome Case Control Study (BMCCS1)

Peri-implant Dermatitis

Netherlands
University of Aberdeen
Friends of ANCHOR

Recruiting

Exploring Mechanism of Action of Dietary Fibre on the Gut Microbiota and Metabolites (MERLIN)

Psyllium | Inulin

United Kingdom
Sanatorio Anchorena San Martin

Completed

Prono Position and Mechanical Power (PROMP)

Acute Respiratory Distress Syndrome

Argentina
Cochlear Bone Anchored Solutions

Completed

Clinical and Health Economic Evaluation With a New Baha® Abutment Combined With a Minimally Invasive Surgical Technique

Hearing Loss | Deafness | Hearing Loss, Conductive | Hearing Loss, Mixed Conductive-Sensorineural

Netherlands, France, Spain, Sweden

Clinical Trials Sponsored by Anchora Medical

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations